Antibody-Mediated Growth Inhibition of Plasmodium falciparum in Kenyan Children and Adults
Author Information
Author(s): Dent Arlene E., Bergmann-Leitner Elke S., Wilson Danny W., Tisch Daniel J., Kimmel Rhonda, Vulule John, Sumba Peter Odada, Beeson James G., Angov Evelina, Moormann Ann M., Kazura James W.
Primary Institution: Case Western Reserve University
Hypothesis
Can antibody-mediated growth inhibition of Plasmodium falciparum be used as a marker of protection against malaria infection in children and adults?
Conclusion
Plasma antibody-mediated growth inhibition of blood stage P. falciparum decreases with age, suggesting that growth inhibition assays may be useful for assessing protection against malaria infection.
Supporting Evidence
- Children exhibited higher growth inhibition levels compared to adults.
- Upper quartile inhibition activity was associated with less risk of infection.
- Growth inhibition decreased progressively with age in children.
Takeaway
Kids have stronger antibodies that help fight malaria than adults, and these antibodies can help protect against getting sick.
Methodology
A treatment-time-to-infection study was conducted over 12 weeks in Kenya, testing plasma from 98 children and 99 adults using growth inhibition assays.
Potential Biases
Potential biases may arise from the selection of participants and the methodologies used in the growth inhibition assays.
Limitations
The study may not be generalizable beyond the specific population in Kenya, and the sample size may limit the power to detect differences in some analyses.
Participant Demographics
Participants included 98 children (average age 7.7 years) and 99 adults (average age 39.4 years) from a malaria holoendemic area in Kenya.
Statistical Information
P-Value
p=0.0003
Confidence Interval
95% CI 1.012–2.329
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website